The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the …

BS Galer, MP Jensen, T Ma, PS Davies… - The Clinical journal …, 2002 - journals.lww.com
Background Several controlled clinical trials have demonstrated the efficacy and safety of
the lidocaine patch 5%(LP) for the treatment of postherpetic neuralgia (PHN). Objective To
assess the effects of the LP on distinct neuropathic pain qualities common to all neuropathic
pain conditions, the authors analyzed data from one of the vehicle-controlled trials in which
the Neuropathic Pain Scale (NPS), the only assessment tool specifically designed to
measure the distinct components of neuropathic pain, was administered. Methods and …